Chhattisgarh clears over Rs 46 crore for new drug-testing lab and FDA building

Written By :  Ruchika Sharma
Published On 2025-12-05 07:00 GMT   |   Update On 2025-12-05 07:00 GMT

Chhattisgarh clears over Rs 46 crore for new drug-testing lab and FDA building

Advertisement
Nava Raipur: In a major boost to the state's food safety and drug testing infrastructure, the Chhattisgarh government has given administrative approval of Rs 46.49 crore to build an Integrated Food and Drug Testing Laboratory cum FDA building in Nava Raipur Atal Nagar.

The project was announced in the budget for the financial year 2025-26 and is expected to strengthen food and drug testing infrastructure across the state.

Advertisement
For the facility, 1.5 acres of land has been allotted in Nava Raipur, it said.
At present, the state's food and drug testing laboratory operates in a 5,000 sqft ground-plus-two storied structure in Raipur. The new laboratory will be spread over 30,000 sqft in a ground-plus-three storied building and equipped with advanced drug and enforcement testing technologies, it said.
With the upgraded facility, the chemical testing capacity will increase from the current 500-800 samples per year to 7,000-8,000 samples annually, PTI reported.
Microbiological tests for products like injections and eye drops will reach 2,000 samples per year, the release said.
Testing of medical items, such as gloves and catheters, will also begin, with an estimated capacity of 500 samples annually. Pharmaceutical sample testing will rise from 50 to nearly 1,000 samples per year, it said.
Health and Family Welfare Minister Shyam Bihari Jaiswal thanked the chief minister for approving the project and said the new laboratory would greatly strengthen the state's food safety framework.
The minister said the enhanced testing capabilities would make processes more transparent, efficient and citizen-friendly, ensuring access to safe, certified and high-quality food products and medicines.
Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News